Acro x Maxcyte | 線上研討會講座 | 細胞與基因治療

Acro x Maxcyte | 線上研討會講座 | 細胞與基因治療



View as Webpage

Guest Speakers

Development of a Non-viral Gene Delivery Platformi.for CAR-T Manufacturing

Dr.Steven A.Feldman, PhD Site Head/Scientific Director

Stanford University Center for Cancer Cell Therapy & Laboratory of Cell and Gene Medicine

Mimic the human intestinal environment by using a microfluidic device to co-culture intestinal epithelium and microorganisms

Yoh-ichi Tagawa, D.Sc. Associate Professor

Tokyo Institute of Technology School of Life Science& Technology

box_light image

主題: 細胞與基因治療

日期: 7月19日 9:00

地點: 線上

細胞和基因治療不僅在學術界取得了重大進展,而且作為一種臨床治療方法也取得了重大進展。參加我們的線上研討會,從最新的類器官疾病模型到試劑和基因修飾新技術,瞭解細胞和基因治療的最新進展,我們ACROBiosystems與MaxCyte共同主辦的線上研討會將於2024年7月19日(上午9:00 -下午12:00)在京都大學Shirankaikan Annex(芝蘭會館別館)舉行。參加我們的線上研討會和線下一起瞭解最新進展,建立與CGT研究員和行業專家的聯繫!


logo image

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.

logoB image

MaxCyte® stands at the forefront of cell-engineering, providing the leading transfection platform powered by our Flow Electroporation® technology, that is instrumental in the discovery and commercialization of cutting-edge cell-based therapies. In 2024, our ExPERT™ electroporation platform is the only proven transfection technology supporting a commercialized non-viral cell therapy. Coupled with our unparalleled scientific, technical and regulatory support, we enable the complex engineering required for the creation of innovative cell therapies. As a trailblazer in this field for 25 years, we are committed to transforming the future of medicine and helping improve patient outcomes. Let MaxCyte be your partner in navigating the exciting landscape of cell therapy development.


Awards & Certifications



LINE 線上諮詢



error: Content is protected !!